Next Article in Journal
Anthropological Research Study of Migrants at the First Aid and Reception Center (CPSA) of Lampedusa
Next Article in Special Issue
Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals
Previous Article in Journal
Intermittent Hypoxia as a Therapeutic Tool to Improve Health Parameters in Older Adults
Previous Article in Special Issue
Validity of Administrative Data for Identifying Birth-Related Outcomes with the End Date of Pregnancy in a Japanese University Hospital
 
 
Article

Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study

1
Materno-Fetal and Obstetrics Research Unit, Department “Woman-Mother-Child”, Lausanne University Hospital, 1011 Lausanne, Switzerland
2
Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland
3
Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, N-0315 Oslo, Norway
4
Swiss Teratogen Information Service and Clinical Pharmacology Service, CHUV, 1066 Lausanne, Switzerland
5
UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tyne NE3 3HD, UK
6
Teratology Information Service, Pharmacovigilance Centre Lareb, ‘s Hertogenbosch, 5237 MH Hertogenbosch, The Netherlands
7
Department of Child Health and Development, Norwegian Institute of Public Health, N-0213 Oslo, Norway
8
School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland
9
Institute of Primary Health Care (BIHAM), University of Bern, CH-3012 Bern, Switzerland
10
Pharmacology & Toxicology, Department of General Internal Medicine, University Hospital of Bern, CH-3010 Bern, Switzerland
11
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
12
L-C&Y—KU Leuven Child & Youth Institute, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Paul B. Tchounwou
Int. J. Environ. Res. Public Health 2022, 19(9), 5335; https://doi.org/10.3390/ijerph19095335
Received: 5 April 2022 / Revised: 24 April 2022 / Accepted: 25 April 2022 / Published: 27 April 2022
(This article belongs to the Special Issue Pharmacotherapy during Pregnancy, Childbirth and Lactation)
Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was distributed in five European countries between June–August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population. View Full-Text
Keywords: pregnancy; postpartum; pharmacoepidemiology; drug utilization; medication use; self-medication; chronic disease; COVID-19; pandemic; Europe pregnancy; postpartum; pharmacoepidemiology; drug utilization; medication use; self-medication; chronic disease; COVID-19; pandemic; Europe
Show Figures

Figure 1

MDPI and ACS Style

Gerbier, E.; Favre, G.; Tauqeer, F.; Winterfeld, U.; Stojanov, M.; Oliver, A.; Passier, A.; Nordeng, H.; Pomar, L.; Baud, D.; Panchaud, A.; Meyer-Massetti, C.; Ceulemans, M. Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study. Int. J. Environ. Res. Public Health 2022, 19, 5335. https://doi.org/10.3390/ijerph19095335

AMA Style

Gerbier E, Favre G, Tauqeer F, Winterfeld U, Stojanov M, Oliver A, Passier A, Nordeng H, Pomar L, Baud D, Panchaud A, Meyer-Massetti C, Ceulemans M. Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2022; 19(9):5335. https://doi.org/10.3390/ijerph19095335

Chicago/Turabian Style

Gerbier, Eva, Guillaume Favre, Fatima Tauqeer, Ursula Winterfeld, Milos Stojanov, Alison Oliver, Anneke Passier, Hedvig Nordeng, Léo Pomar, David Baud, Alice Panchaud, Carla Meyer-Massetti, and Michael Ceulemans. 2022. "Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study" International Journal of Environmental Research and Public Health 19, no. 9: 5335. https://doi.org/10.3390/ijerph19095335

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop